Detailed price information for Zealand Pharma A/S (ZLDPF) from The Globe and Mail including charting and trades.

In a report released yesterday, Ryan Zimmerman from BTIG maintained a Hold rating on Vicarious Surgical. The company’s shares closed last Monday at $9.63. According to TipRanks.com, Zimmerman is ...

Zealand Pharma (ZLDPF) announced that the last participant has been enrolled and randomized to active treatment or placebo in ZUPREME-1, a global Phase 2b trial in people with obesity or ...

Check Out Our Latest Analysis on ZLDPF Zealand Pharma A/S Stock Performance Zealand Pharma A/S stock opened at $84.50 on Friday. The stock’s 50-day moving average is $97.35 and its 200-day ...

Shares of weight loss drug developers gained on Wednesday after Roche (OTCQX:RHHBF) announced a multi-billion-dollar deal with Danish biotech Zealand Pharma (OTCPK:ZLDPF) to jointly develop an ...

SEB Equities upgraded Zealand Pharma (ZLDPF) to Buy from Hold with an DKK 850 price target Easily identify stocks' risks and opportunities. Discover stocks' market position with detailed ...